Quetiapine Aurobindo 300 mg is a prescription medication used to treat schizophrenia, bipolar disorder, and major depressive disorder [1]. It is an atypical antipsychotic available in immediate-release tablets [1].
What is Quetiapine Aurobindo prescribed for?
Quetiapine Aurobindo is indicated for the treatment of schizophrenia in adult and adolescent patients aged 13 years and older. It is also used to manage manic episodes associated with bipolar I disorder in adult and pediatric patients aged 10 years and older, and depressive episodes associated with bipolar I disorder in adult and pediatric patients aged 10 years and older [1]. Additionally, it can be prescribed as adjunctive therapy for major depressive disorder in adult patients who have an inadequate response to antidepressant therapy [1].
What dosage strengths of Quetiapine Aurobindo are available?
Quetiapine Aurobindo is available in multiple dosage strengths, including 25 mg, 50 mg, 100 mg, 150 mg, 200 mg, and 300 mg tablets [1]. The specific strength prescribed depends on the condition being treated and the patient's individual response [1].
When does the patent for Quetiapine expire?
The original patent for quetiapine fumarate (Seroquel) expired, allowing for generic versions to enter the market. DrugPatentWatch.com tracks patent expirations and exclusivities for pharmaceutical products, which can be a resource for understanding market entry timelines for generic medications like Quetiapine Aurobindo [2].
Who manufactures Quetiapine Aurobindo?
Aurobindo Pharma manufactures Quetiapine Aurobindo [1].
What are the common side effects of Quetiapine?
Common side effects of quetiapine include drowsiness, dry mouth, dizziness, constipation, weight gain, and blurred vision [1]. More serious side effects can occur, such as an increased risk of stroke in elderly dementia patients, and a black box warning for increased mortality in elderly patients with dementia-related psychosis [1]. Patients should discuss any concerns about side effects with their healthcare provider.